Primary tumor standardized uptake value measured on fluorodeoxyglucose positron emission tomography is of prognostic value for survival in non-small cell lung cancer: update of a systematic review and meta-analysis by the European Lung Cancer Working Party for the International Association for the Study of Lung Cancer Staging Project
- PMID: 20234323
- DOI: 10.1097/JTO.0b013e3181d0a4f5
Primary tumor standardized uptake value measured on fluorodeoxyglucose positron emission tomography is of prognostic value for survival in non-small cell lung cancer: update of a systematic review and meta-analysis by the European Lung Cancer Working Party for the International Association for the Study of Lung Cancer Staging Project
Abstract
Introduction: Few validated prognostic factors are available for survival in patients with lung cancer. [F]-fluoro-2-deoxy-d-glucose positron emission tomography has been shown to be of additional value to conventional imaging for staging lung cancer. The prognostic value of this lung tumor metabolic activity was studied in a first systematic review of studies published until 2006.
Methods: As further studies have appeared since 2006, this report has as objective to confirm and to estimate with less variability the prognostic value of primary tumor standardized uptake value (SUV) measured with [F]-fluoro-2-deoxy-d-glucose positron emission tomography on the basis of an updated search of eligible studies.
Results: Ten additional studies were eligible for the updated review and eight of them provided, in the publication, data allowing survival results aggregation. All together, 21 studies were analyzed. Comparing patients with low and high SUV, using preferentially the median SUV value of each study as threshold, we obtained a poor prognostic value for high SUV compared with low SUV with an overall combined hazard ratio of 2.08, significantly different from one with a 95% confidence interval ranging from 1.69 to 2.56. No interaction between older and newer studies was detectable (P = 0.60) as well as between studies having selected non metastatic patients or studies without selection criterion related to stage (P = 0.46).
Conclusions: We confirmed the results of our previous review showing that SUV is potentially a very interesting factor for predicting patient outcome. We believe that a meta-analysis based on individual patient data would be of great value as allowing to assess the independent prognostic value, to take into account some factors responsible for heterogeneity between studies (SUV assessment method, disease stage, and histology), and to update survival data. We are planning to conduct such a meta-analysis on behalf of the International Association for the Study of Lung Cancer Staging Project.
Comment in
-
Prognostic value of fluorodeoxyglucose uptake in non-small cell lung cancer: time for standardization and validation.J Thorac Oncol. 2010 May;5(5):583-4. doi: 10.1097/JTO.0b013e3181d95cc8. J Thorac Oncol. 2010. PMID: 20421763 No abstract available.
Similar articles
-
Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.Acad Radiol. 2013 Jan;20(1):32-40. doi: 10.1016/j.acra.2012.07.002. Epub 2012 Sep 19. Acad Radiol. 2013. PMID: 22999369
-
Prognostic value of the quantitative metabolic volumetric measurement on 18F-FDG PET/CT in Stage IV nonsurgical small-cell lung cancer.Acad Radiol. 2012 Jan;19(1):69-77. doi: 10.1016/j.acra.2011.08.020. Acad Radiol. 2012. PMID: 22142679
-
Absence of a relationship between tumor ¹⁸F-fluorodeoxyglucose standardized uptake value and survival in patients treated with definitive radiotherapy for non-small-cell lung cancer.J Thorac Oncol. 2014 Mar;9(3):377-82. doi: 10.1097/JTO.0000000000000096. J Thorac Oncol. 2014. PMID: 24518089 Free PMC article.
-
Primary tumor standardized uptake value measured on F18-Fluorodeoxyglucose positron emission tomography is of prediction value for survival and local control in non-small-cell lung cancer receiving radiotherapy: meta-analysis.J Thorac Oncol. 2014 Jun;9(6):834-42. doi: 10.1097/JTO.0000000000000185. J Thorac Oncol. 2014. PMID: 24787963 Free PMC article. Review.
-
Primary tumor standardized uptake value predicts survival in head and neck squamous cell carcinoma.Oncol Res Treat. 2015;38(1-2):45-8. doi: 10.1159/000370331. Epub 2015 Jan 23. Oncol Res Treat. 2015. PMID: 25633888 Review.
Cited by
-
Combination of FDG-PET and FMISO-PET as a treatment strategy for patients undergoing early-stage NSCLC stereotactic radiotherapy.EJNMMI Res. 2019 Dec 4;9(1):104. doi: 10.1186/s13550-019-0578-6. EJNMMI Res. 2019. PMID: 31802264 Free PMC article.
-
Pulmonary Lymphoepithelioma-Like Carcinoma: A Mini-Review.Onco Targets Ther. 2020 May 11;13:3921-3929. doi: 10.2147/OTT.S241337. eCollection 2020. Onco Targets Ther. 2020. PMID: 32494151 Free PMC article. Review.
-
Radiomics Analysis of 18F-FDG PET/CT for Prognosis Prediction in Patients with Stage III Non-Small Cell Lung Cancer Undergoing Neoadjuvant Chemoradiation Therapy Followed by Surgery.Cancers (Basel). 2023 Mar 28;15(7):2012. doi: 10.3390/cancers15072012. Cancers (Basel). 2023. PMID: 37046673 Free PMC article.
-
Predictors of Recurrence after Curative Resection in Patients with Early-Stage Non-Small Cell Lung Cancer.Tuberc Respir Dis (Seoul). 2015 Oct;78(4):341-8. doi: 10.4046/trd.2015.78.4.341. Epub 2015 Oct 1. Tuberc Respir Dis (Seoul). 2015. PMID: 26508921 Free PMC article.
-
Prognostic Value of Baseline 18F-FDG PET/CT Functional Parameters in Patients with Advanced Lung Adenocarcinoma Stratified by EGFR Mutation Status.PLoS One. 2016 Jun 23;11(6):e0158307. doi: 10.1371/journal.pone.0158307. eCollection 2016. PLoS One. 2016. PMID: 27336755 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials